RESEARCH INST NATIONWIDE CHILDREN'S HOSP
A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment
A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment is a funding opportunity from RESEARCH INST NATIONWIDE CHILDREN'S HOSP, up to 645254, closing May 31, 2029.
May 31, 2029
(1035d left)Overview
SUMMARY: Worldwide, up to 25% of premature infants born prior to 31 weeks gestation, and up to 50% of those born prior to 28 weeks gestation, have neurodevelopmental impairment (NI). The causes of NI are multifactorial, but neuroinflammation is now recognized as a key component. Early life stresses commonly…